Division of Bioengineering Recruiting students for the academic year 2018

Professor Hideaki Tahara
E-mail: tahara{at}
Lab HP

Senior Assistant Professor Hiroaki Uchida
E-mail: hiuchida-tky{at}


【Key Words】cancer therapy, tumor immunity, cancer virus therapy, gene therapy, antibody therapy

 Our division has been conducting basic research projects for development of innovative cancer therapy using immunologic and gene therapy approaches. The reagents, modalities, and concepts developed in this division have been clinically applied as translational research projects. We believe that bidirectional information exchange between the bench and the bedside would be one of the most important requirements for the successful development of novel and effective therapies.
 Ongoing projects include (i) development of cancer immunotherapy using the blockade of mechanisms for immunological evasion of cancer, (ii) development of fully retargeted herpes simplex virus (HSV) vectors for oncolytic virotherapy, and (iii) establishment of highly functional monoclonal antibodies through novel screening methods for targeted cancer therapy.


The University of Tokyo
Graduate School of Frontier Sciences, The University of Tokyo

Page Top